본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Journal of microbiology and biotechnology v.15 no.4, 2005년, pp.740 - 744   피인용횟수: 7

Effect of Bifidobacterium Cell Fractions on IL-6 Production in RAW 264.7 Macrophage Cells

Lee, Byung-Hee    (Department of Food Science and Nutrition, Seoul National University   ); Ji, Geun-Eog    (Research Center, BIFIDO Co., LTD.  );
  • 초록

    Bifidobacterium has been previously shown to potentiate immune function, which was mediated through the stimulation of cytokine production by macrophage. This study was performed to further characterize the effective component of Bifidobacterium by measuring the level of interleukin (IL)-6 cytokine using the RAW 264.7 murine cell line as a macrophage model. RAW 264.7 cells were cultured for 24 h in the presence of whole cells (WCs), cell walls (CWs), and cell-free extracts (CFEs) from various strains of Bifidobacterium and other lactic acid bacteria at various concentrations. The most effective component was different depending on the strains and the concentrations used. When tested with each cell fraction from Bifidobacterium sp. BGN4, heat treatment of the cell fractions lowered the production of IL-6. Synergistic effect was obtained, especially when CWs and CFEs were combined. Sonicated WCs stimulated IL-6 production more than intact WCs. The in vitro approaches employed here should be useful in further characterization of the effects of Bifidobacterium on gastrointestinal and systemic immunity.


  • 주제어

    Bifidobacterium .   IL-6 .   macrophage .   cell fractions.  

  • 참고문헌 (29)

    1. Abbas, A. K., A. H. Lichtman, and J. S. Pobe. 1994. Cytokines, p. 240. In Cellular and Molecular Immunology. 2nd Ed. W. B. Saunders Co., Philadelphia, PA 
    2. Choi, Y J., C. J. Kim, S. Y Park, Y T. Ko, H. K. Jeong, and G E. Ji. 1996. Growth and beta-glucosidase activity of Bifidobacterium. J. Microbiol. Biotechnol. 6: 255-259 
    3. Kanauchi, O., K. Mitsuyama, Y Araki, and A. Andoh. 2003. Modification of intestinal flora in the treatment of int1ammatory bowel disease. Curr. Pharm. Res. 9: 336-346 
    4. Lammers, K. M., P. Brigidi, B. Vitali, P. Gionchetti, F. Rizzello, E. Caramelli, D. Matteuzzi, and M. Campieri. 2003. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 38: 165-172 
    5. Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241 
    6. Rafter, J. J. 1995. The role of lactic acid bacteria in colon cancer prevention. Scand. J. Gastroenterol. 30: 497-502 
    7. Sekine, K., E. Watanabe-Sekine, J. Ohta, T. Toida, T. Tatsuki, T. Kawashima, and Y. Hashimoto. 1994. Induction and activation of tumoricidal cells in vivo and in vitro by the bacterial cell wall of Bifidobacterium infantis. Bifidobact. Microfl. 13: 65-77 
    8. Yasui, H. and M. Ohwaki. 1991. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J. Dairy Sci. 74: 1187-1195 
    9. Sekine, K., J. Ohta, M. Onishi, T. Tatsuki, Y. Shimokawa, T. Toida, T. Kawashima, and Y. Hashimoto. 1995. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium in/antis. Biol. Pharm. Bull. 18: 148-153 
    10. Mitsuoka, T. 1982. Recent trends in research on intestinal flora. Bifidobact. Microfl. 1: 3-24 
    11. Fernandes, C. F. and K. M. Shahani. 1990. Anticarcinogenic and immunological properties of dietary lactobacilli. J. Food Proto 53: 704- 710 
    12. Park, M. S., H. W. Moon, and G. E. Ji. 2003. Molecular characterization of plasmid from Bifidobacterium longum. J. Microbial. Biotechnol. 13: 457-461 
    13. Lee, J., A. Ametani, A. Enomoto, Y. Sato, H. Motoshima, F. Ike, and S. Kaminogawa. 1993. Screening for the immunopotentiating activity of food microorganisms and enhancement of the immune response by Bifidobacterium adolescentis M101-4. Biosci. Biotech. Biochem. 57: 2127-2132 
    14. Namioka, S. 1985. Immunoresponsiveness of newborn piglets and peptidoglycan derived from Bifidobacterium. Bifidobact. Microfl. 4: 3-14 
    15. Sasaki, T., S. Fukami, and S. Namioka. 1994. Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobacterium thermophilum. J. Vet. Med. Sci. 53: 433-437 
    16. Yu, K. W., K. S. Shin, Y. M. Choi, and H. J. Suh. 2004. Macrophage stimulating activity of exo-biopolymer from submerged culture of Lentinus edodes with rice bran. J. Microbiol. Biotechnal. 14: 658-664 
    17. Gomez, E., M. M. Melgar, G P. Silva, A Portoles, and I. Gil. 1988. Exocellular products from Bifidobacterium adolescentis as immunomodifiers in the Iymphoprohferative responses of mouse splenocytes. FEMS Microbiol. Lett. 56: 47-52 
    18. Kim, H. J., J. H. Kim, J. H. Son, H. J. Sea, S. J. Park, M. S. Paek, and S. K. Kim. 2004. Characterization of bacteriocin produced by Lactobacillus bulgaricus. J. Microbiol. Bioteclmol. 14: 503-508 
    19. Strober, W. 1991. Trypan blue exclusion test for cell viability, pp. A.3.3-4.ln J. E. Coligan, A. M. Kruisbeek, D. H. Marguiles, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology. Greene Pub. and Wiley-Interscience, New York, U.S.A, 
    20. Hattori, K., A. Yamamoto, M. Sasai, S. Taniuchi, T. Kojima, Y Kobayashi, H. Iwamoto, K. Namba, and T. Yaeshima. 2003. Effects of administration of bifidobacteria on fecal microtlora and clinical symptoms in infants with atopic dermatitis. Arerugi 252: 20-30 
    21. Hatcher, G E. and R. S. Lambrecht. 1993. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J. Dairy Sci. 76: 2485-2492 
    22. Miettinen, M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human necrosis factor alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64: 5403-5405 
    23. Dong, W., J. I. Azcona-Olivera, K. H. Brooks, J. E. Linz, and J. J. Pestka. 1994. Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma. Toxicol. Appl. Pharmacol. 127: 282-290 
    24. Hosono, A, J. Lee, A Ametani, M. Natsume, M. Hirayama, T. Adachi, and S. Kaminogawa. 1997. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterim adolescentis M 101-4. Biosci. Biotech. Biochem. 61: 312-316 
    25. Ishikawa, H., I. Akedo, Y. Umesaki, R. Tanaka, A. lmaoka, and T. Otani. 2003. Randomized controlled trial ofthe effect of Bifidobacterium-fermented milk on ulcerative colitis. J. Am. Call. Nutr. 22: 256-263 
    26. Kim, I. H., M. S. Park, and G E. Ji. 2003. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocytelike Caco-2 cells. J. Microbiol. Biotechnol. 13: 276-281 
    27. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54: 1-78 
    28. Hughes, D. B. and D. G Hoover. 1991. Bifidobacterium: Their potential for use in American dairy products. Food Technol. 45: 74-83 
    29. Kado-Oka, Y, S. Fujiwara, and T. Hirota. 1991. Effects of Bifidobacterium cells on mitogenic response of splenocytes and several functions of phagocytes. Milchwissenshaft 46: 626-630 
  • 이 논문을 인용한 문헌 (7)

    1. 2006. "" Journal of microbiology and biotechnology, 16(10): 1629~1633     
    2. 2006. "" Journal of microbiology and biotechnology, 16(4): 584~589     
    3. 2006. "" Journal of microbiology and biotechnology, 16(5): 661~666     
    4. 2006. "" Journal of microbiology and biotechnology, 16(7): 1010~1016     
    5. 2006. "" Journal of microbiology and biotechnology, 16(7): 1084~1089     
    6. 2007. "" Journal of microbiology and biotechnology, 17(11): 1862~1867     
    7. 2008. "" Journal of microbiology and biotechnology, 18(4): 686~694     

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기